News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,071 Results
Type
Article (21315)
Company Profile (20)
Press Release (277736)
Multimedia
Podcasts (38)
Webinars (4)
Section
Business (74015)
Career Advice (438)
Deals (11731)
Drug Delivery (30)
Drug Development (74721)
Employer Resources (47)
FDA (8604)
Job Trends (6133)
News (165008)
Policy (15005)
Tag
Academia (1098)
Accelerated approval (6)
Adcomms (28)
Allergies (66)
Alliances (19817)
ALS (85)
Alzheimer's disease (1206)
Antibody-drug conjugate (ADC) (111)
Approvals (8602)
Artificial intelligence (140)
Autoimmune disease (19)
Automation (5)
Bankruptcy (108)
Best Places to Work (5451)
BIOSECURE Act (10)
Biosimilars (49)
Biotechnology (23)
Bladder cancer (74)
Brain cancer (29)
Breast cancer (241)
Cancer (1916)
Cardiovascular disease (151)
Career advice (395)
Career pathing (9)
CAR-T (127)
Cell therapy (321)
Cervical cancer (18)
Clinical research (63668)
Collaboration (444)
Company closure (1)
Compensation (178)
Complete response letters (19)
COVID-19 (1914)
CRISPR (20)
C-suite (106)
Cystic fibrosis (60)
Data (1928)
Decentralized trials (2)
Denatured (15)
Depression (39)
Diabetes (189)
Diagnostics (2084)
Digital health (6)
Diversity (8)
Diversity, equity & inclusion (15)
Drug discovery (79)
Drug pricing (21)
Drug shortages (3)
Duchenne muscular dystrophy (77)
Earnings (32188)
Editorial (20)
Employer branding (5)
Employer resources (43)
Events (44240)
Executive appointments (355)
FDA (9566)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (443)
Gene editing (68)
Generative AI (17)
Gene therapy (236)
GLP-1 (534)
Government (1905)
Grass and pollen (3)
Guidances (86)
Healthcare (7461)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (105)
Indications (26)
Infectious disease (2007)
Inflammatory bowel disease (101)
Inflation Reduction Act (1)
Influenza (33)
Intellectual property (63)
Interviews (78)
IPO (6629)
IRA (10)
Job creations (990)
Job search strategy (340)
Kidney cancer (11)
Labor market (7)
Layoffs (270)
Leadership (5)
Legal (2313)
Liver cancer (62)
Lung cancer (291)
Lymphoma (136)
Machine learning (6)
Management (19)
Manufacturing (136)
MASH (71)
Medical device (4194)
Medtech (4196)
Mergers & acquisitions (5384)
Metabolic disorders (531)
Multiple sclerosis (73)
NASH (20)
Neurodegenerative disease (89)
Neuropsychiatric disorders (26)
Neuroscience (1685)
NextGen: Class of 2025 (2007)
Non-profit (1358)
Now hiring (5)
Obesity (268)
Opinion (131)
Ovarian cancer (73)
Pain (77)
Pancreatic cancer (72)
Parkinson's disease (136)
Partnered (6)
Patents (140)
Patient recruitment (112)
Peanut (39)
People (20014)
Pharmaceutical (7)
Pharmacy benefit managers (1)
Phase I (19898)
Phase II (28325)
Phase III (21378)
Pipeline (1085)
Policy (37)
Postmarket research (1902)
Preclinical (5601)
Press Release (12)
Prostate cancer (90)
Psychedelics (33)
Radiopharmaceuticals (186)
Rare diseases (289)
Real estate (1511)
Recruiting (13)
Regulatory (12352)
Reports (16)
Research institute (1272)
Resumes & cover letters (41)
Rett syndrome (5)
RNA editing (3)
RSV (29)
Schizophrenia (69)
Series A (71)
Series B (62)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (133)
Sponsored (17)
Startups (1376)
Stomach cancer (11)
Supply chain (22)
Tariffs (8)
The Weekly (23)
Vaccines (516)
Venture capitalists (19)
Weight loss (157)
Women's health (28)
Worklife (8)
Date
Last 7 days (580)
Last 30 days (1761)
Last 365 days (19741)
2025 (7105)
2024 (21051)
2023 (23353)
2022 (26763)
2021 (28227)
2020 (25244)
2019 (18497)
2018 (13950)
2017 (16178)
2016 (14224)
2015 (17060)
2014 (11401)
2013 (8504)
2012 (9025)
2011 (9372)
2010 (8873)
Location
Africa (299)
Alabama (39)
Alaska (3)
Arizona (65)
Arkansas (4)
Asia (20683)
Australia (4430)
California (3805)
Canada (1105)
China (384)
Colorado (147)
Connecticut (155)
Delaware (104)
Europe (43596)
Florida (536)
Georgia (133)
Idaho (18)
Illinois (189)
India (13)
Indiana (189)
Iowa (2)
Japan (113)
Kansas (44)
Kentucky (14)
Louisiana (3)
Maine (8)
Maryland (488)
Massachusetts (2748)
Michigan (96)
Minnesota (141)
Missouri (38)
Montana (23)
Nebraska (6)
Nevada (41)
New Hampshire (18)
New Jersey (1132)
New Mexico (13)
New York (1214)
North Carolina (540)
Northern California (1733)
Ohio (114)
Oklahoma (6)
Oregon (21)
Pennsylvania (792)
Puerto Rico (8)
Rhode Island (8)
South America (315)
South Carolina (8)
Southern California (1468)
Tennessee (54)
Texas (583)
United States (13751)
Utah (76)
Virginia (82)
Washington D.C. (34)
Washington State (407)
West Virginia (1)
Wisconsin (24)
299,071 Results for "transperfect trial interactive".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Gedeon Richter Selects Trial Interactive for Clinical Trial Management
TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, announced that Gedeon Richter selected Trial Interactive’s award-winning eTMF platform and TI Collaborate eClinical solution for its upcoming clinical trials.
March 25, 2024
·
3 min read
Pharm Country
TransPerfect Life Sciences and Innovaderm Research Expand Trial Interactive Partnership
TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced that Innovaderm will scale their implementation of Trial Interactive to further enable and optimize remote clinical operations.
February 15, 2022
·
4 min read
Immunology and inflammation
Vyne Crashes After Safety Signal in Dogs Puts Hold on Clinical Trial of Plaque Psoriasis
The hold, placed by the FDA on an early-stage clinical trial of an experimental BET inhibitor, stems from a recent observation of testicular toxicity in canines given the treatment.
April 25, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH DIA
Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the evolution of women’s inclusion in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
March 27, 2025
·
1 min read
·
Lori Ellis
Duchenne muscular dystrophy
Committee Recommends EU Trials of Sarepta’s Elevidys Continue, Day After Holds
One day after the European Medicines Agency requested that three clinical trials of Elevidys be placed on hold after the death of a U.S. teenager, a data monitoring committee concluded that they should continue unchanged.
April 4, 2025
·
2 min read
·
Dan Samorodnitsky
Depression
Neumora Shakes Up Phase III MDD Trials After January Miss
After failing to hit the primary endpoint in a Phase III trial, Neumora is remixing study parameters in two replicate trials, with data expected in the first half of 2026.
March 3, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
April 2, 2025
·
2 min read
Duchenne muscular dystrophy
Wave’s Duchenne Exon-Skipper Reverses Muscle Damage in Mid-Stage Trial
WVE-N531, an oligonucleotide, elicited significant functional benefit and reversal of muscle damage in the Phase II FORWARD-53 trial. Wave plans to file for accelerated approval of the candidate in 2026.
March 26, 2025
·
3 min read
·
Heather McKenzie
Pain
Lexicon to Advance Non-Opioid Painkiller Despite Mid-Stage Trial Failure
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III trials before long.
March 3, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
1 of 29,908
Next
